Skip to main content
. Author manuscript; available in PMC: 2012 Sep 28.
Published in final edited form as: Sci Transl Med. 2012 Mar 28;4(127):127rv4. doi: 10.1126/scitranslmed.3003218

Fig. 2.

Fig. 2

The beneficial effects of aspirin in reducing risk of colorectal cancer show a substantial lag. Data are expressed as a fraction of reduced risk compared to untreated individuals (set at 0). Adapted from randomized controlled trials (6) and observational studies (76).